Home > Insider Trading > Filing (0000905148-17-000939)

Filing Details

Accession Number:: 0000905148-17-000939
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-15 18:38:49
Reporting Period:: 2017-12-15

Accepted Time:: 2017-12-15 18:38:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358762	Reata Pharmaceuticals Inc	RETA	Pharmaceutical Preparations (2834)	113651945

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372218	Cpmg Inc	2000 Mckinney Ave., Ste 2125 Dallas TX 75201		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2017-12-13	19,982	$24.88	462,542	No	4	P	Indirect	By Gallopavo, LP
Class A Common Stock	Acquisiton	2017-12-13	49	$23.98	462,591	No	4	P	Indirect	By Gallopavo, LP
Class A Common Stock	Acquisiton	2017-12-14	14,866	$24.65	477,457	No	4	P	Indirect	By Gallopavo, LP
Class A Common Stock	Acquisiton	2017-12-13	31,471	$24.88	728,503	No	4	P	Indirect	By Roadrunner Fund, LP
Class A Common Stock	Acquisiton	2017-12-13	78	$23.98	728,581	No	4	P	Indirect	By Roadrunner Fund, LP
Class A Common Stock	Acquisiton	2017-12-14	19,672	$24.65	748,253	No	4	P	Indirect	By Roadrunner Fund, LP
Class A Common Stock	Acquisiton	2017-12-13	9,990	$24.88	96,915	No	4	P	Indirect	By Blackwell Partners LLC
Class A Common Stock	Acquisiton	2017-12-13	25	$23.98	96,940	No	4	P	Indirect	By Blackwell Partners LLC
Class A Common Stock	Acquisiton	2017-12-14	6,245	$24.65	103,185	No	4	P	Indirect	By Blackwell Partners LLC
Class A Common Stock	Acquisiton	2017-12-13	59,982	$24.88	393,515	No	4	P	Indirect	By Yellow Warbler, LP
Class A Common Stock	Acquisiton	2017-12-13	148	$23.98	393,663	No	4	P	Indirect	By Yellow Warbler, LP
Class A Common Stock	Acquisiton	2017-12-14	37,492	$24.65	431,155	No	4	P	Indirect	By Yellow Warbler, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Gallopavo, LP
No	4	P	Indirect	By Gallopavo, LP
No	4	P	Indirect	By Gallopavo, LP
No	4	P	Indirect	By Roadrunner Fund, LP
No	4	P	Indirect	By Roadrunner Fund, LP
No	4	P	Indirect	By Roadrunner Fund, LP
No	4	P	Indirect	By Blackwell Partners LLC
No	4	P	Indirect	By Blackwell Partners LLC
No	4	P	Indirect	By Blackwell Partners LLC
No	4	P	Indirect	By Yellow Warbler, LP
No	4	P	Indirect	By Yellow Warbler, LP
No	4	P	Indirect	By Yellow Warbler, LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	110,640	Indirect	By Killdeer Fund, LP
Class A Common Stock	109,415	Indirect	By Mallard Fund, LP
Class A Common Stock	280,500	Indirect	By Willet Fund, LP
Class A Common Stock	37,909	Indirect	By Crested Crane, LP
Class A Common Stock	63,481	Indirect	By Flamingo Fund, LP
Class A Common Stock	334,740	Indirect	By Sandpiper Fund, LP
Class A Common Stock	160,265	Indirect	By Kestrel Fund, LP
Class A Common Stock	11,076	Indirect	By CD Fund, LP
Class A Common Stock	134	Indirect	By Redbird Life Sciences Partners, LP
Class A Common Stock	113	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Class B Common Stock	$0.00	150,186	150,186	Indirect
Class A Common Stock	Class B Common Stock	$0.00	307,776	307,776	Indirect
Class A Common Stock	Class B Common Stock	$0.00	123,379	123,379	Indirect
Class A Common Stock	Class B Common Stock	$0.00	1,490	1,490	Indirect
Class A Common Stock	Class B Common Stock	$0.00	1,251	1,251	Direct

Amount	Remaning Holdings	Nature of Ownership
150,186	150,186	Indirect
307,776	307,776	Indirect
123,379	123,379	Indirect
1,490	1,490	Indirect
1,251	1,251	Direct

Footnotes

This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive.
This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive.
These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date.
The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.